Search results
FDA grants priority review for Neurocrine’s crinecerfont NDAs
Pharmaceutical Technology· 16 hours agoApproval of crinecerfont would also allow Neurocrine to utilise its rare paediatric disease...
Approval of crinecerfont would also allow Neurocrine to utilise its rare paediatric disease...